Diclofenac Sodium / Potassium
Phenylacetic acid NSAID supplied as sodium (15307-79-6, stable/sustained-release) and potassium (15307-81-0, faster-absorbing) salts — USP/EP/BP/IP grade — for tablet, injectable, and topical formulation manufacturing.
Pharmaceutical & Life Science Solutions
NSAIDs, COX inhibitors, and non-NSAID analgesics for pain and inflammation management. Supplied in USP/EP/BP/IP grade for tablet, injectable, and topical formulation manufacturing.
Phenylacetic acid NSAID supplied as sodium (15307-79-6, stable/sustained-release) and potassium (15307-81-0, faster-absorbing) salts — USP/EP/BP/IP grade — for tablet, injectable, and topical formulation manufacturing.
Selective COX-2 inhibitor in IP/BP/USP/EP grade for oral tablet formulation manufacturing. Sourced for osteoarthritis, rheumatoid arthritis, and acute pain treatment product lines.
Propionic acid NSAID in USP/EP/BP grade, available in multiple micronization grades, for oral tablet and suspension formulation manufacturing. Sourced for pain, fever, and inflammation treatment product lines.
Propionic acid NSAID in USP/EP grade for oral tablet, topical gel, and injectable formulation manufacturing. Sourced for arthritis, post-operative pain, and inflammation product lines.
Preferential COX-2 inhibitor in USP/EP/BP/IP grade for oral tablet and injectable formulation manufacturing. Sourced for osteoarthritis and rheumatoid arthritis treatment product lines.
Non-NSAID analgesic-antipyretic in USP/EP/BP grade (high-purity ≥99.9% available) for tablet, capsule, and syrup formulation manufacturing. Sourced for pain and fever management across all age groups.
Long-acting oxicam NSAID in USP/EP/BP grade for oral tablet and topical gel formulation manufacturing. Sourced for once-daily rheumatic disease and acute gout treatment product lines.